← All indications
Drug Resistant Epilepsy
Epileptic condition in which adequate trials of two tolerated and appropriately chosen and used ANTIEPILEPTIC DRUGS schedules to achieve sustained seizure freedom failed.
Drugs by status
Phase 4 trials (18)
Phase 3 trials (6)
Phase 2 trials (10)
Phase 1 trials (6)
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (14)
- UCB
- GlaxoSmithKline
- PTC Therapeutics
- National Institute of Neurological Disorders and Stroke (NINDS)
- Centre Hospitalier St Anne
- University of Toronto
- Columbia University
- University of Alabama, Birmingham
- University of Paris
- University of Western Ontario
- Ontario Brain Institute
- American Epilepsy Society
- Milken Family Foundation
- MedReleaf
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (13)
- Eisai
- GW Pharmaceuticals Ltd.
- University of Pennsylvania
- University of Pittsburgh
- Ain Shams University
- Geisinger Clinic
- MultiCare Health System Research Institute
- University of Florida
- University of Nebraska
- University of Mississippi
- Aix-University of Marseille
- James and Esther King Biomedical Research Program
- Fundación RiojaSalud